Brainstorm Cell Therapeutics Inc. Class Action Lawsuit - BCLI

Company
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI)
Lead Plaintiff Deadline
January 2, 2024 (Expired)
Class Period
August 15, 2022 - September 27, 2023

Expired

Lead Plaintiff Deadline

Jan 2, 2024

Never Miss Another Deadline

Choose your preferred way to stay informed of new case launches and settlement deadlines

WhatsApp

Scan the QR code or click the button to join

Join on WhatsApp

Get Updates by Email

Required Field

Required Field

Required Field

No Spam, opt-out anytime, alert list is free

Allegations

The filed complaint alleges that Brainstorm Cell Therapeutics Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Brainstorm Cell downplayed the severity of the refusal to file letter it received from the U.S. Food and Drug Administration regarding NurOwn ; (2) Brainstorm Cell continued to conceal the risks associated with the submission of the Biologics License Application for NurOwn; and (3) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Eligibility

In order to be eligible to join the BCLI class action lawsuit, you must have incurred a loss on shares of Brainstorm Cell purchased during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in Brainstorm Cell during the relevant time frame or pursuant to the relevant offering(s), you have until January 2, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

TOP